Anna I. Semenova

Saint Petersburg, SPE, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Corrigendum to "Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial" [Eur J Cancer. 227 (2025) 115674].

Corrigendum to "Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial" [Eur J Cancer. 227 (2025) 115674].

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 31, 2025

Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial.

Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 15, 2025

Deposition of Nanostructured Tungsten Oxide Layers by a New Method: Periodic Modulation of the Deposition Angle.

Deposition of Nanostructured Tungsten Oxide Layers by a New Method: Periodic Modulation of the Deposition Angle.

Journal: Langmuir : the ACS journal of surfaces and colloids

Published: August 21, 2023

Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.

Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.

Journal: The oncologist

Published: November 01, 2020

Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection.

Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection.

Journal: Cancer immunology, immunotherapy : CII

Published: November 20, 2019

An Open-Label Study of the Safety and Efficacy of Tag-7 Gene-Modified Tumor Cells-Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer.

An Open-Label Study of the Safety and Efficacy of Tag-7 Gene-Modified Tumor Cells-Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer.

Journal: The oncologist

Published: November 03, 2019

Modern methods of immunotherapy for metastatic melanoma

Modern methods of immunotherapy for metastatic melanoma

Journal: Voprosy onkologii

Published: January 01, 2016

The first results of assessment of clinical efficacy of melatonin and metformin in patients with disseminated skin melanoma receiving dacarbazine as first-line systemic therapy

The first results of assessment of clinical efficacy of melatonin and metformin in patients with disseminated skin melanoma receiving dacarbazine as first-line systemic therapy

Journal: Voprosy onkologii

Published: January 01, 2016

Systemic therapy of soft tissue sarcomas

Systemic therapy of soft tissue sarcomas

Journal: Voprosy onkologii

Published: June 20, 2015

Treatment of patients with disseminated testicular germ cell tumors

Treatment of patients with disseminated testicular germ cell tumors

Journal: Voprosy onkologii

Published: June 20, 2015

Modern methods of molecular targeted therapy for disseminated melanoma

Modern methods of molecular targeted therapy for disseminated melanoma

Journal: Voprosy onkologii

Published: June 20, 2015

Phase II clinical trial of autologous dendritic cell vaccine with immunologic adjuvant in cutaneous melanoma patients

Phase II clinical trial of autologous dendritic cell vaccine with immunologic adjuvant in cutaneous melanoma patients

Journal: Voprosy onkologii

Published: July 11, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026